Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol

Contemporary Clinical Trials 2026

View at publisher
Authors: Samuel A. Wilkinson, Sandhya Prashad, Rachel Dalthorp, Lisa Harding, Brandon M. Kitay, Sagar V. Parikh, James Dziura, Ashley Clayton, Geena Fram, Valerie Lepoutre, Julianna Brown, Robert Ostroff
+1 more Gerard Sanacora
DOI: 10.1016/j.cct.2026.108273
Cited by: 2
References: 35

Fields of Study & Subjects

Treatment of Major Depression Anxiety Depression Psychometrics Treatment Cognitive Processes Tryptophan and brain disorders

Publication details

Journal / source
Contemporary Clinical Trials
Publisher
Elsevier BV
Volume
164
Pages
108273–108273
Publication date
3 March 2026
Language
EN